Adventrx To Develop ANX-188 For Complications Of Arterial Disease - Seeking orphan drug designation in acute limb ischemia (ALI) - Phase 2 clinical proof-of-concept in ALI planned for late 2013/early …
ADVENTRX Announces Corporate Name Change To "Mast Therapeutics, Inc."; Ticker Symbol Change To "MSTX" Name and ticker symbol changes effective March 11, 2013 SAN DIEGO, Feb. 28, 2013 /PRNewswire/ -- …